Related Experiment Video
Updated: May 23, 2026

Cell Based Assays of SINEUP Non-coding RNAs That Can Specifically Enhance mRNA Translation
Published on: February 1, 2019
Emerging therapeutics targeting mRNA translation
Abba Malina1, John R Mills, Jerry Pelletier
1Department of Biochemistry and McGill University, Montréal, Québec H3G 1Y6, Canada.
Abstract:
A defining feature of many cancers is deregulated translational control. Typically, this occurs at the level of recruitment of the 40S ribosomes to the 5'-cap of cellular messenger RNAs (mRNAs), the rate-limiting step of protein synthesis, which is controlled by the heterotrimeric eukaryotic initiation complex eIF4F. Thus, eIF4F in particular, and translation initiation in general, represent an exploitable vulnerability and unique opportunity for therapeutic intervention in many transformed cells. In this article, we discuss the development, mode of action and biological activity of a number of small-molecule inhibitors that interrupt PI3K/mTOR signaling control of eIF4F assembly, as well as compounds that more directly block eIF4F activity.
Insights
Cancer cells hijack protein synthesis via translation initiation complex eIF4F. Small molecules targeting eIF4F assembly and activity offer a promising therapeutic strategy for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cancer is characterized by dysregulated translational control.
- Protein synthesis initiation, particularly the recruitment of 40S ribosomes to mRNA 5'-cap, is a critical regulatory step.
- The eukaryotic initiation factor 4F (eIF4F) complex governs this rate-limiting step.
Purpose of the Study:
- To explore small-molecule inhibitors targeting the eIF4F complex.
- To discuss the development and mode of action of these inhibitors.
- To evaluate their biological activity in cancer therapy.
Main Methods:
- Development of small-molecule inhibitors.
- Investigation of PI3K/mTOR signaling pathways.
- Assessment of direct eIF4F inhibition.
- Evaluation of biological activity and therapeutic potential.
Main Results:
- Small molecules effectively interrupt PI3K/mTOR signaling, impacting eIF4F assembly.
- Compounds directly inhibiting eIF4F activity were developed.
- These inhibitors demonstrate potential for therapeutic intervention in cancer.
Conclusions:
- Targeting translation initiation, specifically the eIF4F complex, presents a viable therapeutic vulnerability in cancer.
- Small-molecule inhibitors offer a promising approach to exploit this vulnerability.
- Further development of these inhibitors holds potential for novel cancer treatments.
Related Concept Videos
Translational Regulation
Leaky Scanning
Improving Translational Accuracy
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life

